Cargando…

The efficacy of pioglitazone for renal protection in diabetic kidney disease

There is limited information on the efficacy of pioglitazone in diabetic kidney diseases (DKD). We evaluated whether pioglitazone exerts renal-protective effects in DKD patients. We designed a retrospective cohort study, which included 742 type 2 diabetes mellitus (T2DM) patients with DKD in Taiwan,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Chao-Chung, Yang, Yi-Sun, Huang, Chien-Ning, Lo, Shih-Chang, Wang, Yu-Hsun, Kornelius, Edy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853567/ https://www.ncbi.nlm.nih.gov/pubmed/35176115 http://dx.doi.org/10.1371/journal.pone.0264129

Ejemplares similares

A randomized, double-blind, placebo-controlled trial to evaluate the hypoglycemic efficacy of the mcIRBP-19-containing Momordica charantia L. fruit extracts in the type 2 diabetic subjects
por: Yang, Yi-Sun, et al.
Publicado: (2022)

Pioglitazone in diabetic kidney disease: forgotten but not gone
por: Papaetis, Georgios S.
Publicado: (2022)

Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats
por: Sun, Li, et al.
Publicado: (2017)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2018)

An Educational Intervention Using Steno Balance Cards to Improve Glycemic Control in Patients With Poorly Controlled Type 2 Diabetes Mellitus
por: WU, Yueh-Chu, et al.
Publicado: (2019)

Reduction of proteinuria by pioglitazone in patients with non-diabetic renal disease
por: Shahidi, Shahrzad, et al.
Publicado: (2011)

Osteoporosis and Stress Urinary Incontinence in Women: A National Health Insurance Database Study
por: Wei, Ming-Cheng, et al.
Publicado: (2020)

Pioglitazone in the Treatment of Type 2 Diabetes: Safety and Efficacy Review
por: Desouza, Cyrus V., et al.
Publicado: (2010)

Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Peng, Chiung-Huei, et al.
Publicado: (2017)

Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study
por: Yen, Chieh-Li, et al.
Publicado: (2020)

Impact of Long Noncoding RNA LINC00673 Genetic Variants on Susceptibility to Diabetic Retinopathy
por: Chuang, Chih-Chun, et al.
Publicado: (2022)

Deep Learning for Automated Diabetic Retinopathy Screening Fused With Heterogeneous Data From EHRs Can Lead to Earlier Referral Decisions
por: Hsu, Min-Yen, et al.
Publicado: (2021)

The Effect of Pioglitazone on Antioxidant Levels and Renal Histopathology in Streptozotocin-Induced Diabetic Rats
por: Kuru Karabas, Munire, et al.
Publicado: (2013)

Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin
por: Lin, Hsin-Chung, et al.
Publicado: (2023)

Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective
por: Kanhai, Anish A., et al.
Publicado: (2020)

Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study
por: Chen, Yu-Hsin, et al.
Publicado: (2016)

The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
por: Li, Yan-Rong, et al.
Publicado: (2021)

Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats
por: Eom, Young Sil, et al.
Publicado: (2016)

The Effects of Pioglitazone on Biochemical Markers of Bone Turnover in the Patients with Type 2 Diabetes
por: Xiao, Wen-hua, et al.
Publicado: (2013)

Association of Long Non-Coding RNA Growth Arrest-Specific 5 Genetic Variants with Diabetic Retinopathy
por: Lee, Chee-Ming, et al.
Publicado: (2022)

Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice
por: Li, Ying, et al.
Publicado: (2019)

Liraglutide protects against glucolipotoxicity‐induced RIN‐m5F β‐cell apoptosis through restoration of PDX1 expression
por: Kornelius, Edy, et al.
Publicado: (2018)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Kim, Jong Ho, et al.
Publicado: (2016)

Pioglitazone use and Parkinson’s disease: a retrospective cohort study in Taiwan
por: Wu, Hsiu-Feng, et al.
Publicado: (2018)

Efficacy and safety of pioglitazone in type 2 diabetes in the Indian patients: Results of an observational study
por: Balaji, Vijayam
Publicado: (2013)

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
por: Kadowaki, Takashi, et al.
Publicado: (2013)

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease
por: Lee, Mei-Yueh, et al.
Publicado: (2014)

Effects of red mold dioscorea with pioglitazone, a potentially functional food, in the treatment of diabetes
por: Chen, Chien-Li, et al.
Publicado: (2015)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
por: Song, Sun Ok, et al.
Publicado: (2012)

Optimal Initial Blood Pressure in Intensive Care Unit Patients with Non-Traumatic Intracranial Hemorrhage
por: Wei, Ming-Cheng, et al.
Publicado: (2020)

Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice
por: Peng, Jun, et al.
Publicado: (2014)

Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity
por: Jacques, Vincent, et al.
Publicado: (2021)

Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
por: Park, Jong Suk, et al.
Publicado: (2011)

Association of Long Noncoding RNA HOTAIR Polymorphism and the Clinical Manifestations of Diabetic Retinopathy
por: Chuang, Chih-Chun, et al.
Publicado: (2022)

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
por: Hanefeld, M
Publicado: (2007)

Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
por: Ferrara, Assiamira, et al.
Publicado: (2011)

Effect of Pioglitazone on Energy Intake and Ghrelin in Diabetic Patients
por: Martin, Corby K., et al.
Publicado: (2010)

Risk management in the treatment of type 2 diabetes with pioglitazone
por: Derosa, Giuseppe, et al.
Publicado: (2009)

Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
por: Zou, Cong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pl1lhev7t78ovm1e2qeiu7jimi